Following Free Radicals With Finesse
A bioresponsive sensor from Carroll lab activates antioxidants only when needed and provides a tool for studying free radicals' role in disease.
Posted in
News
Two Mutations Team Up to Cloak a Deadly Brain Cancer from the Immune System, Study Suggests
Glioblastoma is fast-moving, and the most common type of brain cancer. Two specific cancer cell mutations may work together to help hide these tumors from the immune system, a study from Janiszewska finds.
New Scientist Takes Aim at TB, the World’s Deadliest Infectious Disease
TB is again the world's deadliest infectious disease. Luiz Pedro Carvalho, Ph.D., has joined The Wertheim UF Scripps Institute to develop new therapeutics and better understand the germ.
Researchers Tether Cancer-Killing Natural Product to Cancer-Targeting Antibodies
A team led by chemistry professor Ben Shen, Ph.D., discovered a potent anti-cancer compound within the institute's natural products collection. It has been connected to a precise cancer-seeking antibody with an innovative linker molecule.
First ‘Institute Professor’ of The Wertheim UF Scripps Institute Inventing New Ways to Target Incurable Diseases Via RNA
Matthew Disney, Ph.D. has been named the first Institute Professor of The Wertheim UF Scripps Institute. Disney invented a search-and-destroy system for incurable diseases that targets RNA.
Genetic Cause of ALS and Dementia Repaired by RNA-Targeting Strategy Developed at UF Scripps
“We show for the first time that you can make brain-penetrant molecules that eliminate toxic gene products,” Disney said.
Mining Natural Products Reveals Nature’s Method for Building a Cancer Killer
Enediynes can bind and break DNA, leading to cell death. As a result, they have enormous potential as antibiotics and cancer drugs. A new study reveals how nature assembles them.
Outstanding UF Scripps Inventors Recognized by UF Innovate
Two scientists at UF Scripps have been recognized with "Invention of the Year" awards from UF Innovate. Read about their inventions.
WERTHEIM FOUNDATION PROVIDES LEAD GIFT OF $100 MILLION TO UF SCRIPPS
The transformational lead investment will launch a 10-year, $1 billion public-private partnership — spearheaded by UF Scripps — that is focused on amplifying fundamental science, driving research that translates profound discoveries from bench to bedside to business, training the next generation of innovators and investigators, and improving the health outcomes and experiences of countless patients and families in Palm Beach County, throughout Florida and across the nation.
UF, Scripps Florida Complete Integration to Create Science Research Powerhouse
Two of the nation’s most respected research institutions have closed their transaction that adds a Florida powerhouse meant to accelerate the pace of biomedical discoveries that benefit patients.
